Trials / Unknown
UnknownNCT03475199
Evaluation of Personalised Support Program Effectiveness in Sperm Quality Improvement
Evaluation of FabLife's Personalised Support Program Effectiveness in Sperm Quality Improvement in Men Suffering From Hypofertility
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- FabLife · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
FabLife is an interventional, prospective, multicentre, controlled study undertaken in metropolitan France. The main objective is to evaluate the effect of FabLife personalised program over a period of 15 weeks on the improvement of spermatic DNA fragmentation in subfertile men compared to general dietary recommendations.
Detailed description
More than 15 % of couples couldn't get pregnant after at least a year of unprotected intercourse. The FabLife personalised program aims to improve sperm quality including sperm DNA fragmentation in subfertile men through: * A personalized dietary program based on patient's phenotype and genotype * A daily dietary supplement, developed in the context of male infertility A total of 75 patients will be recruited: * 46 patients will benefit from the program, * 23 patients will form the control group. * 6 patients will not answer to all the criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FabLife | * A personnalized dietary program depending on the patient's phenotype and genotype * The daily intake of a dietary supplement, developped in the context of male infertility. |
Timeline
- Start date
- 2018-02-13
- Primary completion
- 2019-06-01
- Completion
- 2019-12-01
- First posted
- 2018-03-23
- Last updated
- 2019-02-15
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03475199. Inclusion in this directory is not an endorsement.